This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Smiths Medical MD, Inc.
Smiths Medical MD, Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1940, the company has established itself as a leader in innovative medical solutions, particularly in the fields of infusion therapy, vascular access, and respiratory care. Smiths Medical is renowned for its core products, including advanced infusion pumps and precision catheter systems, which are designed to enhance patient safety and improve clinical outcomes. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in developing user-friendly devices that meet the evolving needs of healthcare professionals. With a focus on delivering reliable and effective medical technologies, Smiths Medical continues to play a vital role in enhancing patient care and supporting healthcare providers worldwide.
DitchCarbon Score
How does Smiths Medical MD, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Smiths Medical MD, Inc.'s score of 86 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Smiths Medical MD, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Smiths Group plc, which provides emissions data and climate commitments at a higher corporate level. As part of its climate strategy, Smiths Group plc has set various reduction initiatives, although specific targets for Smiths Medical MD, Inc. have not been detailed. The emissions data and reduction targets are cascaded from Smiths Group plc, which is actively engaged in sustainability efforts, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While Smiths Medical MD, Inc. has not disclosed its own emissions figures or specific reduction targets, it aligns with the broader commitments of its parent company to address climate change and reduce carbon footprints across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,169,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 62,072,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Smiths Medical MD, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
